PODCAST: Energy Infrastructure under the Trump Administration — C&M's Trump: The First Year Series
Client Alert | 1 min read | 09.27.17
In the latest podcast for Crowell & Moring’s “Trump: The First Year” series, Richard Lehfeldt, partner in the firm’s Energy Group, and Diana Jeschke, counsel in the group, sit down to discuss energy infrastructure issues under the Trump Administration. Richard previously worked as counsel for the Energy and Power Subcommittee of the House Energy and Commerce Committee. Diana was an attorney advisor to administrative law judges Carmen Cintron and David Coffman at the Federal Energy Regulatory Commission.
Discussed in this 16-minute podcast:
- An overview of energy infrastructure.
- Who makes decisions about energy infrastructure, where does the funding originate, and what factors go into those decisions.
- An overview of distributed generation and microgrids.
- Case studies: NYU and Princeton University, and what lessons to take from them.
Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes
Insights
Client Alert | 4 min read | 12.04.25
District Court Grants Preliminary Injunction Against Seller of Gray Market Snack Food Products
On November 12, 2025, Judge King in the U.S. District Court for the Western District of Washington granted in part Haldiram India Ltd.’s (“Plaintiff” or “Haldiram”) motion for a preliminary injunction against Punjab Trading, Inc. (“Defendant” or “Punjab Trading”), a seller alleged to be importing and distributing gray market snack food products not authorized for sale in the United States. The court found that Haldiram was likely to succeed on the merits of its trademark infringement claim because the products at issue, which were intended for sale in India, were materially different from the versions intended for sale in the U.S., and for this reason were not genuine products when sold in the U.S. Although the court narrowed certain overbroad provisions in the requested order, it ultimately enjoined Punjab Trading from importing, selling, or assisting others in selling the non-genuine Haldiram products in the U.S. market.
Client Alert | 21 min read | 12.04.25
Highlights: CMS’s Proposed Rule for Medicare Part C & D (CY 2027 NPRM)
Client Alert | 11 min read | 12.01.25
